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The YmdB Phosphodiesterase Is a Global Regulator of Late Adaptive
Responses in Bacillus subtilis
Christine Diethmaier,a Joseph A. Newman,b* Ákos T. Kovács,c* Volkhard Kaever,d Christina Herzberg,a Cecilia Rodrigues,b
Mirjam Boonstra,c Oscar P. Kuipers,c Richard J. Lewis,b Jörg Stülkea
‹Department of General Microbiology, Georg August University Göttingen, Göttingen, Germanya; Institute for Cell and Molecular Biosciences, Newcastle University,
Newcastle upon Tyne, United Kingdomb; Department of Molecular Genetics, University of Groningen, Groningen Biomolecular Sciences and Biotechnology Institute,
Groningen, The Netherlandsc; Research Core Unit for Mass Spectrometry-Metabolomics and Institute of Pharmacology, Hannover Medical School, Hannover, Germanyd
Bacillus subtilismutants lacking ymdB are unable to form biofilms, exhibit a strong overexpression of the flagellin gene hag, and
are deficient in SlrR, a SinR antagonist. Here, we report the functional and structural characterization of YmdB, and we find that
YmdB is a phosphodiesterase with activity against 2=,3=- and 3=,5=-cyclic nucleotide monophosphates. The structure of YmdB
reveals that the enzyme adopts a conserved phosphodiesterase fold with a binuclear metal center. Mutagenesis of a catalytically
crucial residue demonstrates that the enzymatic activity of YmdB is essential for biofilm formation. The deletion of ymdB affects
the expression of more than 800 genes; the levels of theD-dependent motility regulon and several sporulation genes are in-
creased, and the levels of the SinR-repressed biofilm genes are decreased, confirming the role of YmdB in regulating late adaptive
responses of B. subtilis.
Biofilms are complex communities of bacterial cells that can beestablished on solid surfaces or air-liquid interfaces. In the
case of human pathogens, the formation of biofilms on medical
instruments and catheters is a significant problem in hospital-
acquired infections. The complex architecture of a biofilm is
maintained by an extracellular matrix of exopolysaccharide, pro-
tein, and DNA (1, 2). Wild isolates of the Gram-positive model
bacterium Bacillus subtilis also have the potential to form archi-
tecturally complex colonies and pellicles (3) under laboratory
conditions and in their natural environment on the plant rhizo-
sphere (4). Several laboratory strains, such as B. subtilis 168, have
lost their ability to form robust biofilms and seem to have adapted
to cultivation in liquid culture (5).While some laboratory isolates
ofB. subtilis strain 168 lack the expression of biofilm-related genes
and form flat colonies, others can still form architecturally com-
plex colonies (6, 7).
The control of biofilm formation in B. subtilis is dependent on
a molecular switch comprising two transcription repressors and
two antirepressors, which participate in a complex network of
protein-protein interactions that govern the expression of oper-
ons involved in matrix production and autolysis. Central to this
regulatory switch is the repressor SinR (8–10), a DNA binding
protein that represses the transcription of operons involved in
both exopolysaccharide production (3) and the production of the
protein component of the matrix (11). SinR activity is controlled
by the relative levels of various antagonists, the foremost of which
is SinI (8), which causes derepression by binding to SinR. The
SinI-SinR complex is no longer able to bind to DNA (12, 13).
Although sinI and sinR are adjacent on the chromosome, the tran-
scription profile of the sin operon is under complex regulation to
result in an unequal expression profile of the two genes (14, 15).
Two additional proteins, SlrR and SlrA, that also influence this
switch were discovered recently, and these proteins are homo-
logues of SinR and SinI, respectively (16–18). The complex inter-
play between these transcription factors and their antagonists,
their differential expression profiles, and the feedback loops cre-
ated by these interactions explain how B. subtilis is able to adapt to
challenging environmental conditions by specializing in, for in-
stance, motility, genetic competence, sporulation, or cooperation
with other cells to form a biofilm.
YmdB was discovered recently as a factor influencing this de-
cision-making process (19). Mutants lacking ymdB are unable to
formbiofilms and exhibited a strong expression of the genes in the
D-dependentmotility regulon, in particular hag, the gene encod-
ing the flagellin protein. The ymdBmutant had a strong reduction
of slrR expression, and the phenotype could partially be relieved
by overexpressing slrR (19). It is not known how YmdB exerts its
effects on the SlrR-SinR switch. YmdB is homologous to a cal-
cineurin-like phosphodiesterase, DR1281, from Deinococcus ra-
diodurans (20), an enzymewith phosphatase activity against phos-
phoenolpyruvate and with phosphodiesterase activity against
2=,3=-cyclic AMP (cAMP) (20). To determine themolecular func-
tion of YmdB, and thus understand its influence on biofilm for-
mation, we have initiated a structural and functional characteriza-
tion of YmdB. Here, we show that YmdB has a significant metal
ion-dependent phosphodiesterase activity against both 2=,3=- and
3=,5=-cyclic nucleotides, whereas no significant phosphatase activ-
ity was detected. Mutagenesis studies revealed that a lack of the
phosphodiesterase activity is causal for all phenotypes associated
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with a ymdBmutant. We have determined the crystal structure of
YmdB, the active site of which contains essential metal ions and a
phosphate ion that occupies the position of the enzyme’s sub-
strate. Finally, a transcriptomic analysis revealed that over 800
mRNAs are affected by ymdB deletion, and the genes affected con-
firm a central, regulatory role for YmdB in the late adaptive re-
sponses of B. subtilis.
MATERIALS AND METHODS
B. subtilis strains and growth conditions. The B. subtilis strains used in
this work are listed in Table 1. They are derived fromwild-type laboratory
strain 168 or from nondomesticated wild-type strain NCIB3610. B. sub-
tilis was grown in LB medium or in CSE minimal medium containing
succinate and glutamate-ammonium as sources of carbon and nitrogen,
respectively (21). The medium was supplemented with auxotrophic re-
quirements (at 50mg/liter) and glucose as indicated. SP, CSE, orMSgg (3)
plates were prepared by the addition of 17 g Bacto agar/liter (Difco) to the
medium.
DNA manipulation and transformation. B. subtilis chromosomal
DNA was isolated as described previously (21). Escherichia coli strain
DH5 (22) was used for all cloning experiments. All primer sequences are
provided in Table S1 in the supplemental material. Restriction enzymes,
T4 DNA ligase, and DNA polymerases were used as recommended by the
manufacturers, and the combined chain reaction for site-specific mu-
tagenesis (23) was performed with Accuzyme DNA polymerase and ther-
mostable DNA ligase (Ampligase; Epicentre, WI, USA). DNA fragments
were purified from agarose gels by using the QIAquick PCR purification
kit (Qiagen, Germany). Plasmid DNA extraction was performed by using
standard procedures (22). All plasmid inserts derived from PCR products
were verified by DNA sequencing using the dideoxy chain termination
method (22).
Standard procedures were used to transform chemically competent E.
coli cells (22), and transformants were selected on LBplates containing the
appropriate antibiotics. B. subtiliswas transformed with plasmid or chro-
mosomal DNA according to a two-step protocol described previously
(24). Transformants were selected on SP plates containing chloramphen-
icol (Cm) (5 g/ml), kanamycin (Km) (10 g/ml), spectinomycin (Spc)
(100 g/ml), or erythromycin (Em) plus lincomycin (Lin) (1 g/ml and
10 g/ml, respectively).
B. subtilis strain construction. Strains GP966 and GP969, which ex-
press ymdB-cat and ymdBE39Q-cat, respectively (the cat resistance cassette
is placed downstream of the wild-type or mutant ymdB alleles to facilitate
the introduction of point mutations into the chromosome), were ob-
tained by first amplifying ymdB with primers CD95 and ML196 (ymdB-
cat) and with primers CD95 and ML196 and mutagenic primer CD128
(ymdBE39Q-cat). The downstream fragment of ymdB was amplified with
primers ML197 and ML198, and the intervening chloramphenicol resis-
tance cassette was derived from plasmid pGEM-cat (25). The PCR prod-
ucts (upstream, cat, and downstream) were mixed and combined by an-
other PCR using outer primers CD95 and ML196. Finally, strains GP966
and GP969 were constructed by transformation of wild-type strain 168
with the combined PCR products (26).
To transfer mutations into the background of nondomesticated wild-
type strain NCIB3610, SPP1-mediated phage transduction was used as
described previously (19).
Production of recombinant YmdB and YmdBE39Q. Plasmid pGP172
(27) was used to fuse the ymdB variants to a C-terminal Strep-tag (see
Tables S1 and S2 in the supplementalmaterial for details). The PCR prod-
ucts were amplified with primers CD174 and CD93, using chromosomal
DNAs of B. subtilis 168 (for the wild-type ymdB gene) and GP969 (for the
ymdBE39Q allele) as the templates. The PCR products were digested with
SacI and BamHI and cloned into pGP172 linearized with the same en-
zymes. The resulting plasmids, pGP1916 and pGP1917 (see Tables S1 and
S2 in the supplemental material for details), were used for protein pro-
duction inE. coli. Similarly, C-terminallyHis6-taggedYmdBwas prepared
by amplification ofB. subtilis 168 genomicDNAwith primersNcoFor and
BamRev2 (see Table S1 in the supplemental material). The resultant PCR
product was ligated into the transfer vector pGEM-T Easy (Promega) and
transformed into E. coli DH5, where the presence of the insert was ver-
ified by blue/white screening. For subcloning into pET28a, the ymdB in-
sert was liberated from pGEM-T Easy by restriction using NcoI and
BamHI and subsequently ligated into similarly restricted pET28a.
Recombinant YmdB proteins were expressed in E. coli BL21(DE3)
strains by isopropyl--D-thiogalactopyranoside (IPTG) induction (final
concentration, 1 mM) in exponentially growing cultures. Cells were har-
vested by centrifugation 4 h after induction and were lysed either by son-
ication or with a French press. After lysis, the crude extracts were centri-
fuged at 15,000  g for a minimum of 30 min. Strep-tagged YmdB was
purified by Streptactin affinity chromatography (IBA, Göttingen, Ger-
many); the bound proteins were eluted with 2.5 mM desthiobiotin (Sig-
ma-Aldrich). The relevant protein-containing fractions were combined
and dialyzed overnight. YmdB-His6 was purified by nickel-immobilized
metal affinity chromatography using a His-Trap column (GE Health-
care). Bound proteins were elutedwith imidazole before pooling, concen-
trating, and loading onto a Superdex 200 gel filtration column. The purity
of YmdB-His6 was estimated to be90% by SDS-PAGE.
Enzyme assays. The assays for phosphatase and phosphodiesterase
activities of Strep-tagged YmdB were performed as described previ-
ously (20). Phosphatase activity against para-nitrophenol phosphate
(pNPP) was assayed in a buffer containing 300 mM Tris-HCl (pH 7.5),
1 mMMnCl2, 1 mM dithiothreitol (DTT), 25 mM pNPP, and different
amounts of Strep-tagged YmdB in a total volume of 1 ml. The YmdB
phosphodiesterase activity against bis-pNPP was assayed in a buffer
containing 300 mM Tris-HCl (pH 8.5), 0.5 mM MnCl2, 1 mM DTT, 0
to 15 mM bis-pNPP, and different amounts of Strep-tagged YmdB in a
total volume of 1 ml.
Phosphodiesterase activity with cyclic nucleotides wasmeasured by
using a quantitative assay as previously described (20, 28). The activity
was assayed in a 400-l reaction mixture containing 50 mM morpho-
lineethanesulfonic acid (MES)-KOH buffer (pH 6.25), 0.2 mMMnCl2,
0 to 5 mM substrate, and different amounts of Strep-tagged protein (0
to 2 g).
To detect potential diguanylate cyclase activity of YmdB, assays were
performed as follows: 100 nM YmdB in a solution containing 50 mM
Tris-HCl buffer (pH7.8), 10mMMgCl2, and 0.1%bovine serumalbumin
(BSA)was preincubated for 10min at 30°Cwith shaking at 300 rpm. After
addition of 100 M (each) GTP and MgCl2 (final volume, 100 l), incu-
bation times of 1 and 18 h, respectively, were chosen. The reactions were
stopped by heating the samples for 5 min at 95°C. The samples were
centrifuged for 10 min at 14,000 rpm at 4°C. The supernatants were ana-
lyzed for cyclic di-GMP (c-di-GMP) by liquid chromatography-coupled
tandemmass spectrometry (LC-MS/MS), as described previously (29). In
parallel, the assays were also performedwith the E. coli diguanylate cyclase
YdeH (29).
TABLE 1 B. subtilis strains used in this study
Strain Genotype or description Source or referencea
168 trpC2 Laboratory collection
GP583 trpC2 ymdB::spc 19
GP921 NCIB3610 ymdB::spc 19
GP922 trpC2 ymdB::cat 19
GP966 trpC2 ymdB-cat LFH-PCR ¡ 168
GP969 trpC2 ymdBE39Q-cat LFH-PCR ¡ 168
GP1618 NCIB3610 ymdB-cat GP966 ¡ NCIB3610
GP1619 NCIB3610 ymdBE39Q-cat GP969 ¡ NCIB3610
NCIB3610 Wild type Laboratory collection
a Arrows indicate construction by transformation or transduction. LFH-PCR, long
flanking homology PCR.
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In all kinetic experiments,Km andVmax were determined by nonlinear
curve fitting from Lineweaver-Burk plots.
Analysis of the cyclic dinucleotide pools. The concentration of cyclic
dinucleotides in B. subtilis cells was determined by a LC-MS/MS method
essentially as described previously (30, 31). Briefly, cells were cultivated in
SP medium, pelleted, and lysed in a Micro Dismembrator S instrument
(Sartorius). The resulting cell powder was used to extract the metabolites,
and the driedmetabolite extracts were dissolvedwith 200l of H2O. After
repeated centrifugation and addition of internal standards ([13C,15N]c-
di-GMP and [13C,15N]c-di-AMP), part of the extracts was analyzed by
LC-MS/MS.
Quantification of cyclic dinucleotides byMS/MS.Chromatographic
separation was performed on a series 200 high-performance liquid chro-
matography (HPLC) system (PerkinElmer Life Sciences), as described
previously (31). Analyte detection was performed on an API 3000 triple-
quadrupole mass spectrometer equipped with an electrospray ionization
source (AB Sciex), using selected reaction monitoring (SRM) analysis in
the positive ionization mode. The SRM transitions labeled “quantifier”
were used to quantify the compound of interest, whereas “identifier” SRM
transitions were monitored as confirmatory signals. The quantifier SRM
transitions were the most intense and were therefore used for quantifica-
tion.
X-ray crystallography.YmdB-His6 was buffer exchanged into 10mM
Na-HEPES–100 mM NaCl and concentrated to 10 mg/ml. Crystals of
YmdB-His6 were obtained by sparse-matrix screening against a range of
commercially available screens. The crystals used for structure determi-
nation were obtained from well solutions containing 0.2 M sodium ace-
tate–20%polyethylene glycol 3350 (PEG3350) andwere cryoprotected by
soaking for 30 s in well solution supplemented with 20% (vol/vol) ethyl-
ene glycol before being loop mounted and plunged into a pool of liquid
nitrogen. The crystals belonged to the primitive monoclinic space group
P21 and diffracted to 1.64-Å resolution on beamline I02 at the Diamond
Light Source. Diffraction data were processed using XDS (32), and the
structure was solved by molecular replacement using the program
PHASER (33), with the structure of DR1281 from D. radiodurans (20)
(PDB accession number 1T70) as the searchmodel. Manual alterations to
the model were made in COOT (34) and interspersed with rounds of
refinement in PHENIX.REFINE (35) to convergence, with a finalRfactor of
0.159 and a finalRfree of 0.185. Themodel was restrained to standard bond
lengths and angles, with over 96% of residues occupying themost favored
regions of the Ramachandran plot. The final YmdB structure superim-
poses onDR1281 (20) (PDB accession number 1T70), using 247matched
C atoms with a root mean square deviation (RMSD) of 1 Å. A summary
of the data collection and refinement statistics can be found in Table 2.
Assays of complex colony formation. For the analysis of colony ar-
chitecture,B. subtilis strainswere precultured in LB to an optical density at
600 nm (OD600) of 0.6 to 0.8. A total of 1.5 ml of the culture was pelleted
and resuspended in 100 l of sterile supernatant. Ten microliters of this
cell suspensionwas then spotted ontominimalMSgg–1.5%agar plates (3)
and incubated at 22°C for 3 to 5 days. The colonies were photographed by
using an Olympus SZX12 stereomicroscope.
Analysis of flagellin protein expression. To monitor the expression
patterns of the flagellin protein Hag, the strains were grown in CSE min-
imal medium with glucose (CSE-Glu medium) and harvested in the log-
arithmic phase of growth. The cells were disrupted by sonication, and 15
g crude extract of each culture was loaded onto a 12% sodium dodecyl
sulfate-polyacrylamide gel. Following electrophoresis, the gel was stained
with Coomassie brilliant blue G-250. The band corresponding toHag was
confirmed by mass spectrometry (19).
Northern blot analysis. B. subtilis strains 168 (wild type) and GP583
(ymdB mutant) were grown in CSE minimal medium containing 0.5%
glucose and were harvested when the culture reached stationary phase.
The preparation of total RNA andNorthern blot analysis were carried out
as described previously (36). Digoxigenin (DIG) RNA probes were ob-
tained by in vitro transcriptionwith T7RNApolymerase (RocheDiagnos-
tics), using PCR-generatedDNA fragments as templates. The primer pairs
used to amplify DNA fragments specific for sspB and sigG are listed in
Table S1 in the supplemental material. The reverse primer contained a T7
RNA polymerase recognition sequence. In vitro RNA labeling, hybridiza-
tion, and signal detectionwere carried out according to the instructions of
the manufacturer (DIG RNA labeling kit and detection chemicals; Roche
Diagnostics). RNA stability was analyzed as described previously (15).
Briefly, rifampin was added to stationary growing cultures (final concen-
tration, 100 g/ml), and samples were taken at the time points indicated.
Quantification was performed by using Image J software v1.42 (37).
Real-time quantitative reverse transcription-PCR. For real-time
quantitative reverse transcription-PCR (qRT-PCR), RNA isolation pro-
ceeded as described above. cDNAs were synthesized by using the One-
Step RT-PCR kit (Bio-Rad) as described previously (19). qRT-PCR was
carried out on an iCycler instrument (Bio-Rad), according to the manu-
facturer’s recommended protocol, by using the primers indicated in Table
S1 in the supplemental material. Data analysis and the calculation of ex-
pression ratios as fold changes were performed as described previously
(19). qRT-PCR experiments were performed in duplicate.
Transcriptome analysis.Cells were grown inCSE-Glumedium. Sam-
ples of wild-type and ymdBmutant strains were harvested by centrifuga-
tion (10,397 g for 1 min at 4°C) at mid-exponential phase and 2 h after
the transition point. A total of four independent biological replicates were
included. The pellets were frozen immediately in liquid nitrogen and
stored at 	80°C. RNA extraction was performed with the Macaloid/
Roche protocol (38). RNA concentration and purity were assessed by
using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scien-
tific). RNA samples were reverse transcribed into cDNA by using the
TABLE 2 Data collection and refinement statistics for YmdB




a, b, c, (Å) 73.8, 106.0, 77.9
, , 
 (°) 90, 108.3, 90
Wavelength (Å) 0.98








No. of unique reflections 134,017 (16,090)










Bond lengths (Å) 0.015




a Rmerge hkli|Ii	 Im|/hkliIi, where Ii and Im are the observed intensity and mean
intensity of related reflections, respectively.
b Values in parentheses are for the highest-resolution shell, 1.73 to 1.64 Å.
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Superscript III reverse transcriptase kit (Invitrogen, Carlsbad, CA, USA)
and labeled with Cy3 or Cy5 monoreactive dye (GE Healthcare, Amer-
sham, The Netherlands). Labeled and purified cDNA samples (Nucleo-
spin Extract II; Biokè, Leiden, The Netherlands) were hybridized in Am-
bion Slidehyb 1 buffer (Ambion Europe Ltd.) at 48°C for 16 h. The arrays
were constructed as described previously (39). Slide spotting, slide treat-
ment after spotting, and slide quality control were done as described pre-
viously (40). After hybridization, slides were washed for 5 min in 2 SSC
(1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate) with 0.5% SDS,
twice for 5 min in 1 SSC with 0.25% SDS, and 5 min in 1 SSC 0.1%
SDS and then dried by centrifugation (2 min at 2,000 rpm) and scanned
with a GenePix 4200AL scanner (Axon Instruments, CA, USA). Fluores-
cent signals were quantified by using ArrayPro 4.5 (Media Cybernetics
Inc., Silver Spring, MD, USA) and further processed and normalized with
MicroPrep (39). CyberT (41) was used to perform statistical analysis.
Genes with a Bayes P value of 10	5 or lower were considered significantly
affected.
Accession numbers. Microarray data are MIAME compliant, and
the raw data have been deposited in the MIAME-compliant Gene Ex-
pression Omnibus database (accession no. GSE39142) in accordance
with MGED Society instructions (http://www.mged.org/Workgroups
/MIAME/miame.html) The atomic coordinates and structure factor am-
plitudes have been deposited in the PDB under accession no. 4B2O.
RESULTS
YmdB is a phosphodiesterase.YmdB is annotated in databases as
a protein of unknown function or as a putative phosphatase/phos-
phodiesterase (42), activities that have already been described for
DR1281, a 2=,3=-cyclic AMP phosphodiesterase from D. radio-
durans with 44% sequence identity to YmdB (20). We therefore
tested the potential phosphatase and phosphodiesterase activities
of YmdB using purified, recombinant protein. YmdB had negligi-
ble enzymatic activity against pNPP, classically used as a synthetic
phosphatase substrate, and no activity could be detected with
phosphoenolpyruvate as the substrate (Table 3). In contrast,
YmdB displayed measureable phosphodiesterase activity against
bis-pNPP as the substrate, with a Km of 9.4 10
	4 M and a Vmax
of 105.21 mol/min/mg (Table 3).
Thephosphodiesterase activity ofYmdB is necessary for bio-
film formation.Wehave shown previously that ymdBmutants do
not form biofilms because the corresponding set of genes is not
expressed and the flagellin-encoding hag gene is overexpressed
(19). In order to assess the phosphodiesterase activity of YmdB in
biofilm formation, we constructed two isogenic strains that ex-
pressed either wild-type YmdB (GP966) or the E39Q variant
(GP969). E39 is predicted by sequence homology to DR1281 (and
indeed confirmed by our structural analysis of YmdB [see below])
to coordinate divalent cations, essential for catalysis, in the en-
zyme’s active site. To make sure that the mutation does not affect
the stability of the protein variant, we compared the intracellular
accumulations of the wild-type and themutant YmdB proteins by
Western blotting. The E39Q substitution did not result in any
change of stability (data not shown). Moreover, a corresponding
set of strains in the background of nondomesticated wild-type
strain NCIB3610 was constructed. As shown in Fig. 1A, wild-type
strain B. subtilisNCIB3610 formed rough colonies that are indic-
ative of the expression of biofilm genes. As observed previously,
TABLE 3 Kinetic parameters for enzymatic reactions catalyzed by YmdB variantsa
Reaction and protein Km (M)
Mean Vmax




Phosphatase reaction, substrate pNPP
WT ND 0.05
E39Q ND 0.05
Phosphatase reaction, substrate PEP
WT ND
Phosphodiesterase reaction, substrate bis-pNPP
WT 9.40 (1.8) 10	4 105 27.0 23.1 103 12.7 103 2.46 107
E39Q ND 0.05
a WT, wild type; PEP, phosphoenolpyruvate; ND, not determined.
FIG 1 Biofilm formation and flagellin synthesis in ymdB variants. (A) Colony surface architectures of individual colonies grown on MSgg medium are shown. The
strains used were as follows: the wild-type (WT) strains (NCIB3610) and the ymdB (GP921), ymdB-cat (GP1618), and ymdBE39Q-cat (GP1619)mutants. The scale bar
is 0.25 cm. (B)The expression levels of flagellin (Hag) of different strains are compared. Crude extractswere isolated fromB. subtilis strains. Lane 1, 168 (wild type); lane
2, GP583 (ymdB::spc); lane 3, GP922 (ymdB::cat); lane 4, GP966 (ymdB-cat); lane 5, GP969 (ymdBE39Q-cat). The flagellin protein Hag is indicated with an arrow.
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ymdB mutant strain GP921 formed absolutely smooth colonies
because of a lack of biofilm gene expression (19). As expected,
strain GP1618 formed rough colonies morphologically identical
to those of wild-type B. subtilis strain NCIB3610. Strain GP1619,
expressing the ymdBE39Q allele, formed smooth colonies that were
indistinguishable from those formedby the ymdBdeletionmutant
(Fig. 1A). As a marker for the expression of motility genes, we
made use of the strong overexpression of hag that was detected
previously in ymdBmutant strain GP583 and confirmed by mass
spectrometry and the use of a hag mutant (19). Strain GP969,
carrying the ymdBE39Q allele, resulted in strong overexpression of
Hag to levels observed in the ymdB deletion mutant (Fig. 1B).
Deletion of ymdB affects 800 mRNAs. Inactivation of ymdB
drastically affects the transcription of motility and biofilm genes
(19). Moreover, the presence of the ymdB gene in a transcription
unitwith rny, encoding themajor endoribonucleaseRNaseY (19),
might imply that YmdB exerts some control over global mRNA
accumulation in B. subtilis. Consequently, microarray analyses
were performed to compare the transcript profiles of wild-type
strain 168 and isogenic ymdB mutant strain GP583 in the expo-
nential and stationary growth phases. The microarray analyses
revealed that the levels of over 800 mRNAs were changed by the
deletion of ymdB. Microarray comparison of the ymdBE39Q strain
(GP969) to its isogenic wild-type strain (GP966) showed that a
near-identical set of genes was significantly up- or downregulated
in both the exponential and the stationary phases. Among the
genes with most strongly increased and decreased expression lev-
els, i.e., 10-fold, were the D-dependent motility regulon and
the SinR-repressed biofilm genes, respectively, a finding that is in
agreement with previous results (19) (see Tables S3 and S4 in the
supplemental material). A complete list of the mRNAs affected by
the loss of ymdB or the ymdBE39Qmutation is provided in theGEO
database (accession no. GSE39142).
In addition to the D regulon, we also observed increased ex-
pression levels of a group of operons involved in sugar utilization.
Collectively, these operons are under the control of phospho-
transferase system-controlled transcriptional activators (the lev,
man, andmtl operons, required for fructose, mannose, and man-
nitol utilization, respectively [43]). The levels of the mRNAs cor-
responding to these operons were increased in the ymdB mutant
in both the exponential and stationary phases. Moreover, a strong
accumulation of the mRNA levels of several sporulation-specific
genes was observed during the stationary phase in the ymdBmu-
tant. Specifically, many of these genes encode the small acid-sol-
uble proteins that protect the DNA of the spore (44). Most of the
mRNAs accumulating during stationary phase depend on the spo-
rulation-specific sigma factorsF andG,which recognize quite sim-
ilar promoters (45). G-dependent gene transcription has been re-
ported previously for a lon protease mutant under nutritional and
genetic conditions in which sporulation is prevented (46).
To verify the results concerning the sporulation-specific
mRNAs, we performedNorthern blot analyses for sspB and theG
gene, sigG. SspB is a small acid-soluble protein with DNA-protec-
tive properties (44), and the sigma factor G is required after en-
gulfment of the prespore in the progression beyond morphologi-
cal stage III (47). Under the growth conditions used, neither the
sspB nor the sigG transcript accumulated to any great extent in the
wild-type strain (Fig. 2A), whereas in the ymdBmutant, the levels
of both transcripts were significantly enhanced (Fig. 2A), con-
firming the results of the transcriptome analysis. By Northern
blotting, the half-life of the sspB transcript inwild-typeB. subtilis is
13 min, whereas in the ymdB null mutant, the sspB transcript
half-life is a little longer, at 17 min (Fig. 2B). By qRT-PCR, very
comparable half-lives of 12.1 and 16.6 min in the presence and
absence of YmdB, respectively, were obtained. When sigG tran-
script stability was measured by Northern blotting, the half-life
was 2.6 min in the presence and 2.8 min in the absence of YmdB
(Fig. 2B); by qRT-PCR, the half-lives were 4.1 and 5.5min, respec-
tively. Therefore, YmdB affects the transcript accumulation, but
not the half-life, of sporulation-specific genes in its role as a late
adaptive response regulator.
Crystal structure of YmdB. To gainmolecular insight into the
phosphodiesterase activity of YmdB, its crystal structure was de-
termined and refined to a resolution of 1.64 Å (Fig. 3A). Relevant
crystallographic statistics are provided in Table 2. Overall, the
electron density map is of excellent quality, such that almost the
entire length of all 4 chains in the asymmetric unit could be traced.
As expected, YmdB adopts the calcineurin-like fold, a large and
functionally diverse family that includes phosphodiesterases, pro-
tein (Ser/Thr) phosphatases, and 5=-nucleotidases (48). A VAST
search of the Protein Data Bank (PDB) identifies 22 homologous
structures above a P value threshold of 10	7, three-quarters of
which are unpublished outputs from structural genomics consor-
tia. Common to all members of this family is a conserved 
architecture (Fig. 3A) that serves as a scaffold for the coordination
of a pair of divalent metal ions in the enzyme active site (Fig. 3B
andC). In the case of YmdB, both-sheets are six stranded and are
of a mixed parallel/antiparallel nature; the -sheets are flanked by
FIG 2 Effect of YmdB on the sporulation genes sspB and sigG. (A) Northern blot analyses to test the effect of YmdB on the expression of sspB and sigG. The
transcripts were detected with riboprobes specific for sspB and sigG. (B) The transcript stability of sspB and sigGmRNAs was determined for the wild type (168)
and the ymdBmutant (GP583) by Northern blotting. Above each lane is the time (in minutes) after rifampin addition. The half-life of each mRNA transcript is
also indicated in minutes. In the lane with the RNA from the ymdB strain, larger amounts of sspB and sigG mRNAs are detectable, but these mRNAs are not
stabilized in comparison to the wild type.
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-helices on both sides. An extended loop between 11 and 12
forms a flap that protrudes away from the rest of the molecule
(Fig. 3A).
YmdB quaternary structure. The four chains in the asymmet-
ric unit of YmdB crystals are virtually identical (0.3-Å RMSDon
C atoms) and associate with each other to formpairs of dimers in
a tetrameric D2 assembly with dimensions of 45 Å by 65 Å by 75 Å.
The most significant interface links chains A and B (and is dupli-
cated in chains C and D) and is dominated by contacts from 9 to
the extended loop linking11 to12, which also contains6. The
interface accounts for 1,630Å2 of interface area (14%of the total
monomer-accessible surface area) and is a mixture of both polar
(10 hydrogen bonds and 2 salt bridges) and nonpolar interactions.
The secondary interface that links chains A to C (and chains B to
D) ismuch less extensive, burying only 500Å2 of accessible surface
area, and consists solely of nonpolar interactions. By size exclu-
sion chromatography, YmdB elutes in a major fraction at an ex-
pected molecular mass of 55 kDa (data not shown), consistent
with a dimer of YmdB assembled presumably by the interaction
between chains A and B (Fig. 3D).
The catalytic machinery of YmdB. A pair of divalent metal
ions, each coordinated in an octahedral fashion, is located in a
shallow cleft between the two-sheets (Fig. 3B andC). Since there
were no metal ions or chelating agents added during purification,
the two metal ions must have been retained by YmdB during pu-
rification. They have beenmodeled as iron ions following analysis
of purified protein samples by inductively coupled plasma mass
spectrometry, which revealed 2 molar equivalents of iron, and the
presence of iron in YmdB crystals was confirmed by fluorescence
scans prior to data collection (see Fig. S1 in the supplemental
material). We suggest that the site contains Fe2 and Fe3 ions, in
an arrangement described previously for purple acid phosphatases
(49), members of the same enzymatic superfamily as YmdB. The
Fe2 ion is coordinated predominantly by soft ligands: the N1
and Nε2 imidazole nitrogens of His175 and His150, respectively;
the carboxamide oxygen of Asn67; and a carboxylic oxygen of
Glu39. The octahedral coordination is completed by an oxygen
from a bound phosphate ion and a water, both of which also
provide a ligand to the Fe3 ion (Fig. 3B andC). His175 is the only
outlier in the Ramachandran plot but is very well defined in the
electron density and makes several ionic interactions with sur-
rounding residues as well as its Fe2 ion interaction. The Fe3 ion
is coordinated by a higher proportion of harder-charged oxygen
atoms: a carboxylic oxygen of Asp8, the same carboxylate oxygen
of Glu39 as that used in the Fe2 site, the carboxamide oxygen of
Asn40, and the Nε2 imidazole nitrogen of His177. The shared
water and another oxygen from the same phosphate ion complete
the coordination (Fig. 3B and C). All the ligands are between 2.05
Å and 2.21 Å away from the metal ions. Consistent with the Fe
ionization states ascribed, the 2mFo-DFc electron density map
peak heights in all four copies in the asymmetric unit are signifi-
cantly lower for the Fe3 site, between 14.8 and 16.5, than for the
Fe2 ion, between 17.8 and 19.2 , as would be expected of an ion
with one less electron.
The metal ions and their coordinating residues superimpose
closely on other structures from the calcineurin-likemetallophos-
phodiesterase family. The coordinating residues are mostly very
well conserved in both chemical identity and position in the pro-
tein sequence (Fig. 4A). However, the presence of a water mole-
cule bound to both metal ions is almost universal, reinforcing the
idea that once activated to form a hydroxide, this solventmolecule
acts as the nucleophile in catalysis. The phosphate is situated di-
rectly above the metal ions, in a position that presumably mimics
that of the substrate. The geometry of the two Fe ions in relation to
the phosphate is highly indicative of an associative in-line mech-
FIG 3 Crystal structure of YmdB. (A) Stereographic ribbon representation of
the YmdB monomer, with -helices in blue and -sheets in green. Secondary
structural elements are labeled according to topology. The active-site environ-
ment is also depicted, in stickmode colored by atom type, with bound ions and
the proposed catalytic water as spheres. (B) The active site of YmdB, with key
amino acids highlighted as sticks and colored by atom type. The final 2mFo-
DFc electron density map is contoured at a level of 1.9 and is shown as a gray
mesh. An anomalous-difference Fourier series, using phases calculated from
the refined model, is contoured at a level of 5  (pink). The only peaks of this
height in the Fourier series correspond to the two Fe ions at the active site. (C)
The active site of YmdB in the same orientation as that in panel B, with key
amino acids highlighted as sticks and colored by atom type. Hydrogen bonds
are shown as dashed black lines. (D) The YmdBdimer, with each chain colored
independently. Helix 6 from chain A (blue) packs above the region sur-
rounding strands 9 and 11 in chain B (green).
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anism (Fig. 3C). Numerous hydrogen bonds are made by the
phosphate to nearby side chains and water molecules, including
the invariant His68, a key determinant of 2=,3=-cyclic nucleotide
phosphodiesterase activity (50). His68 is part of a conserved His-
Asp dyad, which presumably orients the histidine with respect to
the leaving group for the donation of a proton from the former to
the latter (Fig. 3C).
YmdB and 2=,3=- and 3=,5=-cyclic nucleotides. Given the ho-
mology of YmdB to D. radiodurans DR1281 (20), we determined
the kinetic parameters of YmdB against several cyclic mononucle-
otides. To avoid any redox complications, and becausemanganese
also supports the phosphodiesterase activity of YmdB (see Fig. S2
in the supplemental material), we conducted all biochemical ex-
periments in the presence of manganese. YmdB is active against
2=,3=- and 3=,5=-cyclic mononucleotides, with kinetic parameters
described in Table 4. In general terms, the Km values for the 2=,3=-
FIG 4 The YmdB active site. (A) Stereo view of a comparison of the active site of YmdB (green) to 3 other representative calcineurin-like metallophosphoes-
terases that contain a dimetal cluster: the putative 5=-nucleotidase from E. coli (PDB accession no. 3IVD) (in pink), the Rv0805 nucleotide phosphodiesterase
fromMycobacterium tuberculosis (PDB accession no. 2HY1) (51) (in blue), and the secreted phosphoesterase YfkN from B. subtilis (PDB accession no. 3GVE)
(64) (in gray). DR1281 is not used for this comparison because the deposited structure does not contain metal ions. (B) Binding of 2=,3=-cAMP by YmdB. The
phosphate anions of YmdB and the model coordinates of 2=,3=-cAMP were superimposed by least-squares minimization. The protein surface is drawn as a
semitransparent surface, with the protein backbone drawn as a C trace, and the side chains of several likely substrate specificity determinants are drawn. (C)
Proposed reaction scheme for YmdBwith 2=,3=-cAMPas a representative of the phosphodiesterase activity. A pair ofmetal ions in theYmdB active site coordinate
both the phosphate moiety of the substrate and an active-site water molecule, conserved in other structures of the calcineurin-like phosphodiesterase superfam-
ily, which is perfectly positioned to perform nucleophilic attack on the substrate once activated to form a hydroxyl ion. A key role for Glu39 is confirmed
experimentally here; the spatial arrangement of His68 and Asp71 in relation to each other and the bound phosphate is consistent with His68 and Asp71 acting
as a classic catalytic dyad, with His68 serving as an acid and protonating the O2=-leaving group to facilitate its displacement.
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cyclic mononucleotides tested were 4 to 5 times lower than those
for their 3=,5= mononucleotide counterparts; the Vmax values
showed the opposite correlation, being 2 to 3 times higher for the
2=,3=-cyclic mononucleotides than for the 3=,5= variants. The con-
sequent10-fold differences in kcat/Km values indicate that YmdB
has a preference for 2=,3=-cyclic mononucleotides, which is per-
haps not surprising, as B. subtilis is unable to form either of the
signaling nucleotides 3=,5=-cAMP and 3=,5=-cGMP. In all cases,
mutation of Glu39 to the isosteric glutamine abolished the phos-
phodiesterase activity almost completely (Table 4), confirming
that Glu39 plays a key role in catalysis because of its role in coor-
dinating correctly the dinuclear metal center (Fig. 3B and C and
4A and B), which will be lost in the glutamine mutant. Using the
phosphate ion bound to YmdB as a guide, 2=,3=-cAMP can be
positioned into the active site without significant steric clashes to
the protein, with the adenine in the energetically favored anti
conformation and with the O2=-leaving group in line with the
incoming hydroxyl (Fig. 4B and C). Many structures that are ho-
mologous to YmdB also contain a phosphate, or a phosphate-
containing compound, in a position similar to that observed in
YmdB (51–55).With the exception of direct hydrogen bonding to
the phosphate oxygens, there are, in general, very few direct con-
tacts between enzyme and substrate (51), and thus, the means by
which substrate specificity occurs in the superfamily is obscure.
The catalytic properties of several metal-dependent phos-
phodiesterases against 2=,3=-cAMP have been measured (20, 50,
56). Among the enzymes tested are representatives of the HD
phosphohydrolases, the EAL diguanylate phosphodiesterases, the
metallo--lactamases, and the DHH phosphatases. The Km ob-
served for YmdB against 2=,3=-cAMP (0.2 mM) is toward the
lower end of the range of the enzymes tested (Km values of between
0.05 mM and 35 mM), although the YmdB kcat (15 min
	1) indi-
cates that it is one of the slowest enzymes tested (kcat values of
between 0.13 min	1 and 15,000 min	1). An unusual facet of
YmdB is its ability to hydrolyze both 2=,3=- and 3=,5=-cyclic nucle-
otides; the latter activity is generally not found in phosphodies-
terases, including D. radiodurans DR1281 (20). Nonetheless, the
finding that a number of characterized enzymes have catalytic
properties similar to or better than those of YmdB when tested
against physiological substrates other than 2=,3=-cyclic nucleo-
tides suggests that 2=,3=-cAMP is not the primary target of YmdB.
Effect of YmdB on cyclic dinucleotide pools. If cAMP were
not the physiological target of YmdB, cyclic dinucleotides would
be an attractive alternative.We considered the secondarymessen-
ger cyclic di-GMP, which has been shown to influence biofilm
formation in various other bacteria (57). Recently, both c-di-
GMP and c-di-AMP have been shown to be present in B. subtilis
(31, 58–62), and there are several c-di-GMP and c-di-AMP syn-
thases and hydrolases in the B. subtilis genome, strongly suggest-
ing an important physiological role for these molecules (42). To
test the involvement of YmdB in the homeostasis of these mole-
cules, we performed two sets of experiments. First, we determined
the intracellular pools of c-di-AMPand c-di-GMP.While the con-
centration of c-di-AMP (about 15.3 0.21 and 13.4 1.71 ng of
c-di-AMP per mg of protein for the wild-type strain and isogenic
ymdB mutant strain GP583, respectively) was not affected by the
ymdBmutation, a strong effect was observed for c-di-GMP. In the
wild-type strain, a concentration of 34.81 (2.30) ng of c-di-GMP
per mg of protein was detected. In contrast, a concentration of
only 1.24 (0.01) ng of c-di-GMP per mg of protein was deter-
mined for isogenic ymdBmutant strain GP583.
The reduced concentration of c-di-GMP reported above seems
to be counterintuitive for a phosphodiesterasemutant. Therefore,
we also tested the cyclic dinucleotide hydrolase activity of YmdB in
vitro. To test whether YmdB degrades cyclic dinucleotides, we
incubated recombinant YmdBwith both cyclic di-AMP and cyclic
di-GMP in vitro, but we were unable to find any traces of product
formation by thin-layer chromatography (TLC), reverse-phase
HPLC, or anion-exchange chromatography (data not shown).
This obvious lack of in vitro c-di-GMP phosphodiesterase activity
is in good agreementwith the in vivo observations. To test whether
YmdB might have an unexpected diguanylate cyclase activity, we
incubated YmdB with GTP and assayed for c-di-GMP produc-
tion. In parallel, the experiment was performed with the E. coli
diguanylate cyclase YdeH (29). While YdeH exhibited the ex-
pected diguanylate cyclase activity, no activity was detectable for
YmdB. Thus, the involvement of YmdB in the control of the in-
tracellular c-di-GMP pool seems to be indirect (see Discussion).
DISCUSSION
YmdB belongs to the large (15,000 members) calcineurin-like
phosphatase/phosphodiesterase family present in all domains of
life, representatives of which participate in diverse functions, in-
cluding phosphodiesterase, phosphomonoesterase, nucleotidase,
or nuclease activities. We show here by transcriptome analyses
that YmdB is also a key regulator in the decision-making processes
of biofilm formation, motility, and sporulation, mutually exclu-
sive late adaptive responses of Bacillus subtilis. YmdB does not
participate directly in the network of protein-protein interactions
that constitute the Sin/Slr epigenetic switch (19), so the question
arises, how does YmdB, a phosphodiesterase, exert global control
in this bacterium?
Twopossibilities could be taken into consideration.On the one
hand, YmdBmight be directly implicated inRNA synthesis and/or
degradation of the target genes. On the other hand, YmdB might
perform an enzymatic reaction that gives rise to the observed tran-
scriptome and phenotypic changes in a rather indirect way.
If YmdBwere directly involved in controlling mRNA accumu-
lation, it would most likely act at the level of mRNA stability. The
fact that YmdB is encoded in an operon with the essential endo-
nuclease RNase Y lends support for this hypothesis (19).However,
the structure of YmdB does not support a role in direct RNA
binding. Although other members of the calcineurin-like phos-
TABLE 4 Kinetic parameters for phosphodiesterase activity catalyzed by
YmdB
Protein and










2=,3=-cAMP (2.00.2) 10	4 0.83 0.23 15.0 11.0 7.5 104
2=,3=-cGMP (2.90.6) 10	4 1.02 0.17 22.1 11.4 7.6 104
3=,5=-cAMP (1.3 0.3) 10	3 0.45 0.04 9.2 2.4 7.0 103
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phodiesterases, such as the Mre11 DNA endonuclease, are able to
hydrolyze nucleic acids (62), the binding and recognition of nu-
cleic acids are performed primarily by other domains that are not
present in YmdB. The recognition and degradation of the tran-
scripts of key regulators could be achieved by the interaction of
YmdB with other RNA-responsive macromolecules, and through
these interactions, specific substrates are presented to the YmdB
active site. However, there is little overlap between the transcripts
affected by rny and ymdB disruption. Moreover, there was no
difference between wild-type and ymdB mutant strains in the
RNase Y-dependent processing of the gapA operon mRNA (data
not shown). The transcript stabilities of the sporulation genes sspB
and sigG were found to have a very slight (1.3-fold) increase in
the mRNA half-life in the absence of YmdB, consistent with the
modest increase in the half-life (1.7-fold) found previously for
the monocistronic hag mRNA (19). The transcriptome data sug-
gest that ymdB inactivation results in the coordinated deregula-
tion of complete regulons, indicating that YmdB affects specifi-
cally the expression and/or activity of the cognate regulators
rather than all of the individual genes. In fact, this has already been
demonstrated for the D- and SinR-controlled motility and bio-
film regulons, respectively; reduced expression of the regulator
SlrR is responsible for the effects of the ymdB deletion (19).
In conclusion, the effect of the ymdB deletion on mRNA accu-
mulation and, thus, on biofilm formation is likely to be an indirect
result of the phosphodiesterase activity of YmdB. While we have
determined phosphodiesterase activity for YmdB against both
2=,3=- and 3=,5=-cyclic nucleotides, it is not clear at present if either
of these substrates exists to any significant extent in B. subtilis.
Neither free 3=,5=-cAMP (63) nor 3=,5=-cAMP-responsive catabo-
lite activator protein (CAP)-like proteins have been found in B.
subtilis. Moreover, although some trans-phosphorylation RNA
degradation reactions, such as those catalyzed by RNase A and
RNase I, produce 2=,3=-cyclic nucleotides (64), there are very few
reports of 2=,3=-cyclic nucleotides being isolated from biological
systems, perhaps because of the relative susceptibility of these nu-
cleotides to hydrolysis by nonspecific phosphodiesterases (56).
The exclusion of cyclic mononucleotides makes cyclic dinucle-
otides the next attractive potential direct YmdB target. Indeed,
c-di-GMP is implicated in the control of biofilm formation in
many species (57). Our determination of the pools of cyclic di-
nucleotides revealed a strong reduction of the c-di-GMP levels in
the ymdBmutant. However, this effect in vivo is not supported by
the biochemical activity of YmdB in vitro: the protein neither de-
grades c-di-GMP (as one might assume for a phosphodiesterase)
nor produces the cyclic dinucleotide (as would be in perfect agree-
ment with the results of the nucleotide measurements). If not by
its direct enzymatic activity, how could YmdB otherwise affect
c-di-GMP levels? The transcriptome analysis suggests an answer
to this question. In the ymdB mutant, expression levels of the
c-di-GMP-specific phosphodiesterases YkoW and YuxH are in-
creased 4.6- and 2.4-fold, respectively. This may result in the de-
creased intracellular c-di-GMP concentration.
Two recent studies have addressed the role of c-di-GMP in
biofilm formation in B. subtilis (58, 59). However, whereas one
report suggested an implication of c-di-GMP in biofilm formation
(58), the other excluded this possibility. Therefore, the question of
whether the alteration of the c-di-GMP pools in the ymdBmutant
only parallels the effects on biofilm formation and motility regu-
lon expression or whether there is a causal relation remains open
to further investigation.
The observation of increased phosphodiesterase expression
with its consequences for the c-di-GMP pool and biofilm forma-
tion brings us back to the question of the initial and primary
activity of YmdB. The identification of the primary target that is
subject to YmdB-mediated hydrolysis will be the major focus of
future work.
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